AIM ImmunoTech Inc. AIM
0.12 USD 0.00 (+1.08%)
As ofNov 20, 2026, 11:15 AM EST
0.115 Day range 0.1219
0.12 52-week range 1.54
- YTD
- -88.97%
- 1 year
- -90.37%
News
globenewswire.com AIM ImmunoTech Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting OCALA, Fla., Nov. 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that its 2026 Annual Meeting of Stockholders (the “Annual Meeting”),…
globenewswire.com AIM ImmunoTech Approaches Major Clinical Inflection Point with Phase 2 Pancreatic Cancer Data Expected Q1 2027; Reports Third Quarter 2026 Financial Results Expanding scientific rationale for Ampligen® in the evolving pancreatic cancer treatment landscape, including potential complementary approaches with RAS-targeted therapiesbenzinga.com AIM ImmunoTech Q3 EPS $(0.21) Misses $(0.14) Estimate, Sales $22.000K Down From $26.000K YoY AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 61.54 percent. This is a 86.62 percent increase over losses of…
